

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.35255891 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.35255891 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.87007269 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81808891 |
| 5 | positive thymic T cell selection (GO:0045059) | 4.58033986 |
| 6 | positive regulation of defense response to virus by host (GO:0002230) | 4.45472310 |
| 7 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.44183031 |
| 8 | positive regulation of heat generation (GO:0031652) | 4.37967285 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.36650395 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 4.32662517 |
| 11 | cellular response to exogenous dsRNA (GO:0071360) | 4.30266052 |
| 12 | fucose catabolic process (GO:0019317) | 4.17808611 |
| 13 | L-fucose metabolic process (GO:0042354) | 4.17808611 |
| 14 | L-fucose catabolic process (GO:0042355) | 4.17808611 |
| 15 | thymic T cell selection (GO:0045061) | 3.99249863 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94409656 |
| 17 | tryptophan catabolic process (GO:0006569) | 3.86696218 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 3.86696218 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 3.86696218 |
| 20 | positive T cell selection (GO:0043368) | 3.83729681 |
| 21 | negative T cell selection (GO:0043383) | 3.81827187 |
| 22 | regulation of heat generation (GO:0031650) | 3.77009227 |
| 23 | viral transcription (GO:0019083) | 3.75581179 |
| 24 | negative thymic T cell selection (GO:0045060) | 3.75543360 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.70904818 |
| 26 | cellular response to ATP (GO:0071318) | 3.70322522 |
| 27 | T cell selection (GO:0045058) | 3.67522603 |
| 28 | regulation of vitamin metabolic process (GO:0030656) | 3.59340176 |
| 29 | kynurenine metabolic process (GO:0070189) | 3.56719424 |
| 30 | translational termination (GO:0006415) | 3.56595958 |
| 31 | negative regulation of mast cell activation (GO:0033004) | 3.54988803 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 3.52904138 |
| 33 | negative regulation of telomere maintenance (GO:0032205) | 3.50102339 |
| 34 | regulation of memory T cell differentiation (GO:0043380) | 3.44955206 |
| 35 | regulation of fever generation (GO:0031620) | 3.39904721 |
| 36 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.38943312 |
| 37 | regulation of chronic inflammatory response (GO:0002676) | 3.38875518 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.38418273 |
| 39 | interferon-gamma production (GO:0032609) | 3.37911523 |
| 40 | behavioral response to nicotine (GO:0035095) | 3.36839338 |
| 41 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32448585 |
| 42 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.32427655 |
| 43 | COPI coating of Golgi vesicle (GO:0048205) | 3.32067864 |
| 44 | Golgi transport vesicle coating (GO:0048200) | 3.32067864 |
| 45 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.30530495 |
| 46 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.28142683 |
| 47 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.27381679 |
| 48 | multicellular organism reproduction (GO:0032504) | 3.20812906 |
| 49 | response to interleukin-15 (GO:0070672) | 3.19763516 |
| 50 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.19368633 |
| 51 | protein targeting to ER (GO:0045047) | 3.16425394 |
| 52 | cotranslational protein targeting to membrane (GO:0006613) | 3.12610773 |
| 53 | regulation of defense response to virus by host (GO:0050691) | 3.12066687 |
| 54 | translational elongation (GO:0006414) | 3.11270220 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 3.06998506 |
| 56 | tryptophan metabolic process (GO:0006568) | 3.05751987 |
| 57 | regulation of T-helper 1 type immune response (GO:0002825) | 3.03823514 |
| 58 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.02288913 |
| 59 | platelet dense granule organization (GO:0060155) | 3.00889210 |
| 60 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.00329256 |
| 61 | sulfation (GO:0051923) | 2.99375476 |
| 62 | desmosome organization (GO:0002934) | 2.98607579 |
| 63 | NIK/NF-kappaB signaling (GO:0038061) | 2.97849182 |
| 64 | positive regulation of histone deacetylation (GO:0031065) | 2.93685709 |
| 65 | positive regulation of tolerance induction (GO:0002645) | 2.92286463 |
| 66 | hemidesmosome assembly (GO:0031581) | 2.92263078 |
| 67 | sphingoid metabolic process (GO:0046519) | 2.92070455 |
| 68 | response to pheromone (GO:0019236) | 2.91059576 |
| 69 | cellular response to zinc ion (GO:0071294) | 2.90312439 |
| 70 | protein localization to endoplasmic reticulum (GO:0070972) | 2.89005535 |
| 71 | hepatocyte apoptotic process (GO:0097284) | 2.88708043 |
| 72 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.87554551 |
| 73 | viral life cycle (GO:0019058) | 2.85795812 |
| 74 | keratinocyte development (GO:0003334) | 2.85576699 |
| 75 | ribosomal small subunit biogenesis (GO:0042274) | 2.84759456 |
| 76 | magnesium ion transport (GO:0015693) | 2.84529454 |
| 77 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.82401877 |
| 78 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.81284285 |
| 79 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.80988468 |
| 80 | cellular response to interleukin-15 (GO:0071350) | 2.80090259 |
| 81 | sphingosine metabolic process (GO:0006670) | 2.79230986 |
| 82 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.79027549 |
| 83 | positive regulation of prostaglandin secretion (GO:0032308) | 2.78311478 |
| 84 | regulation of respiratory burst (GO:0060263) | 2.78169563 |
| 85 | keratinocyte proliferation (GO:0043616) | 2.77477115 |
| 86 | endoderm formation (GO:0001706) | 2.75960606 |
| 87 | leukocyte aggregation (GO:0070486) | 2.75392056 |
| 88 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.75232699 |
| 89 | diol metabolic process (GO:0034311) | 2.71310016 |
| 90 | regulation of B cell differentiation (GO:0045577) | 2.71244723 |
| 91 | B cell receptor signaling pathway (GO:0050853) | 2.69771725 |
| 92 | tolerance induction (GO:0002507) | 2.68897287 |
| 93 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68365036 |
| 94 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67834826 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66969649 |
| 96 | interferon-gamma secretion (GO:0072643) | 2.66840145 |
| 97 | cellular protein complex disassembly (GO:0043624) | 2.66535611 |
| 98 | regulation of chemokine biosynthetic process (GO:0045073) | 2.66256859 |
| 99 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.65894424 |
| 100 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.65831021 |
| 101 | keratinization (GO:0031424) | 2.64226628 |
| 102 | mitotic cell cycle arrest (GO:0071850) | 2.63167868 |
| 103 | establishment of endothelial barrier (GO:0061028) | 2.62960811 |
| 104 | DNA deamination (GO:0045006) | 2.62870658 |
| 105 | piRNA metabolic process (GO:0034587) | 2.62106201 |
| 106 | negative regulation of lipid storage (GO:0010888) | 2.60163469 |
| 107 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.57725469 |
| 108 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.57544254 |
| 109 | translational initiation (GO:0006413) | 2.57111636 |
| 110 | T cell receptor signaling pathway (GO:0050852) | 2.55074576 |
| 111 | cellular biogenic amine catabolic process (GO:0042402) | 2.54902015 |
| 112 | amine catabolic process (GO:0009310) | 2.54902015 |
| 113 | T cell migration (GO:0072678) | 2.54436627 |
| 114 | regulation of tolerance induction (GO:0002643) | 2.54314506 |
| 115 | cornea development in camera-type eye (GO:0061303) | 2.54125804 |
| 116 | regulation of mesoderm development (GO:2000380) | 2.54122813 |
| 117 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.53245913 |
| 118 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.53142090 |
| 119 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52255709 |
| 120 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.52150938 |
| 121 | establishment of skin barrier (GO:0061436) | 2.51979767 |
| 122 | protein retention in ER lumen (GO:0006621) | 2.51659167 |
| 123 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.51457282 |
| 124 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.51453688 |
| 125 | regulation of action potential (GO:0098900) | 2.50242188 |
| 126 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.49935222 |
| 127 | endothelial tube morphogenesis (GO:0061154) | 2.49296329 |
| 128 | morphogenesis of an endothelium (GO:0003159) | 2.49296329 |
| 129 | regulation of immunoglobulin secretion (GO:0051023) | 2.49170467 |
| 130 | molting cycle (GO:0042303) | 2.48386494 |
| 131 | hair cycle (GO:0042633) | 2.48386494 |
| 132 | positive regulation of calcium ion import (GO:0090280) | 2.47801372 |
| 133 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.47792200 |
| 134 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.47009792 |
| 135 | protein K11-linked deubiquitination (GO:0035871) | 2.46507123 |
| 136 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.46308635 |
| 137 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.46128417 |
| 138 | positive regulation of respiratory burst (GO:0060267) | 2.45933520 |
| 139 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.45442288 |
| 140 | regulation of hippo signaling (GO:0035330) | 2.45062334 |
| 141 | maturation of SSU-rRNA (GO:0030490) | 2.43969747 |
| 142 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.43917074 |
| 143 | T cell costimulation (GO:0031295) | 2.43595048 |
| 144 | positive regulation of action potential (GO:0045760) | 2.42925665 |
| 145 | response to type I interferon (GO:0034340) | 2.42577791 |
| 146 | lymph node development (GO:0048535) | 2.42082592 |
| 147 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.41929148 |
| 148 | protein complex disassembly (GO:0043241) | 2.41582376 |
| 149 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.41368098 |
| 150 | positive regulation of protein deacetylation (GO:0090312) | 2.41091246 |
| 151 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.41030200 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.39661352 |
| 153 | regulation of response to interferon-gamma (GO:0060330) | 2.39287335 |
| 154 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.38904205 |
| 155 | detection of light stimulus involved in visual perception (GO:0050908) | 2.38904205 |
| 156 | lymphocyte costimulation (GO:0031294) | 2.38439567 |
| 157 | regulation of natural killer cell activation (GO:0032814) | 2.38149822 |
| 158 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.38052618 |
| 159 | trophectodermal cell differentiation (GO:0001829) | 2.36773559 |
| 160 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.36564494 |
| 161 | positive regulation of isotype switching (GO:0045830) | 2.35033581 |
| 162 | snRNA transcription (GO:0009301) | 2.35002070 |
| 163 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.34231282 |
| 164 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.34231282 |
| 165 | positive regulation of fatty acid transport (GO:2000193) | 2.33682104 |
| 166 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.33475862 |
| 167 | regulation of acrosome reaction (GO:0060046) | 2.32400588 |
| 168 | parturition (GO:0007567) | 2.32235545 |
| 169 | positive regulation of immunoglobulin production (GO:0002639) | 2.32026591 |
| 170 | type I interferon signaling pathway (GO:0060337) | 2.31739600 |
| 171 | cellular response to type I interferon (GO:0071357) | 2.31739600 |
| 172 | cellular ketone body metabolic process (GO:0046950) | 2.31392931 |
| 173 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.30730984 |
| 174 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.30673005 |
| 175 | positive regulation of interleukin-12 production (GO:0032735) | 2.29619126 |
| 176 | natural killer cell differentiation (GO:0001779) | 2.29197183 |
| 177 | NAD biosynthetic process (GO:0009435) | 2.29088299 |
| 178 | positive regulation of interleukin-2 production (GO:0032743) | 2.28951728 |
| 179 | positive regulation of icosanoid secretion (GO:0032305) | 2.28455743 |
| 180 | positive regulation of protein kinase C signaling (GO:0090037) | 2.28244750 |
| 181 | regulation of interferon-alpha production (GO:0032647) | 2.27213648 |
| 182 | positive regulation of natural killer cell activation (GO:0032816) | 2.27025327 |
| 183 | negative regulation of phagocytosis (GO:0050765) | 2.26972810 |
| 184 | DNA methylation involved in gamete generation (GO:0043046) | 2.25512098 |
| 185 | glomerular filtration (GO:0003094) | 2.24210033 |
| 186 | natural killer cell activation (GO:0030101) | 2.22878199 |
| 187 | alpha-beta T cell activation (GO:0046631) | 2.22708852 |
| 188 | T cell apoptotic process (GO:0070231) | 2.22679435 |
| 189 | negative regulation of bone resorption (GO:0045779) | 2.19743810 |
| 190 | macromolecular complex disassembly (GO:0032984) | 2.19406675 |
| 191 | protein targeting to membrane (GO:0006612) | 2.18566434 |
| 192 | leukocyte cell-cell adhesion (GO:0007159) | 2.16949031 |
| 193 | positive regulation of B cell differentiation (GO:0045579) | 2.16890320 |
| 194 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.14146659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.39674605 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.12117124 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.84625469 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.68500547 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.55186798 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.20268060 |
| 7 | * MYC_22102868_ChIP-Seq_BL_Human | 3.20077678 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.99784226 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.70979309 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.40059932 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.39533816 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.34366919 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22685383 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.20349921 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.18436078 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.15855491 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12518130 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11698498 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08218781 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03822792 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03505401 |
| 22 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02143420 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02079661 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.00182522 |
| 25 | * MYB_26560356_Chip-Seq_TH1_Human | 1.99565628 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96595270 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94674777 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93081884 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.89969283 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89602898 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85590784 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78145670 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71598689 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.70346309 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68727329 |
| 36 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67667802 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66229269 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65829753 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64092499 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62221564 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.61645488 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60033572 |
| 43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.57473739 |
| 44 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55685923 |
| 45 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.54064955 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.53538402 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51562122 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50949861 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50863006 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50845057 |
| 51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.48530973 |
| 52 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.47207948 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47086460 |
| 54 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46688144 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46549615 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46058647 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44160635 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43690436 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43022020 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42991025 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.42987719 |
| 62 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.42606947 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41752024 |
| 64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41519183 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40814285 |
| 66 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39784072 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.36172900 |
| 68 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35831435 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35289205 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34080352 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34022533 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33838621 |
| 73 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.32739781 |
| 74 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.32739781 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31973593 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31875980 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.31822228 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31288031 |
| 79 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31085569 |
| 80 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31085569 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30589859 |
| 82 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30538695 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.29581411 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28788957 |
| 85 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28724738 |
| 86 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.28615324 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27930180 |
| 88 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27133119 |
| 89 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25320714 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25187242 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24280366 |
| 92 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23968067 |
| 93 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23699636 |
| 94 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23450630 |
| 95 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22780454 |
| 96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21744430 |
| 97 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.21429792 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20954772 |
| 99 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.20891263 |
| 100 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18362952 |
| 101 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17938058 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17791144 |
| 103 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17058767 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16257975 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15886230 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15029077 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14662417 |
| 108 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14563345 |
| 109 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14084918 |
| 110 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13998383 |
| 111 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13564494 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12518508 |
| 113 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12500646 |
| 114 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12190332 |
| 115 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12176971 |
| 116 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.12126565 |
| 117 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12118730 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11215724 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11140410 |
| 120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11109083 |
| 121 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11042457 |
| 122 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11042457 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11041388 |
| 124 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10572121 |
| 125 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10157590 |
| 126 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.09593681 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08787771 |
| 128 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08384674 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07418582 |
| 130 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07266561 |
| 131 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07152635 |
| 132 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06357238 |
| 133 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05929528 |
| 134 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05565001 |
| 135 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05565001 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05538169 |
| 137 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05267091 |
| 138 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05087838 |
| 139 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04408025 |
| 140 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04350134 |
| 141 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04226388 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04198172 |
| 143 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03950055 |
| 144 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02701899 |
| 145 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.02698620 |
| 146 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02683658 |
| 147 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02234549 |
| 148 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01585643 |
| 149 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00795185 |
| 150 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00705098 |
| 151 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00663135 |
| 152 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00373668 |
| 153 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00365743 |
| 154 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00265780 |
| 155 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00025040 |
| 156 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99749396 |
| 157 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99604848 |
| 158 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99263805 |
| 159 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99236080 |
| 160 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98757138 |
| 161 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98111758 |
| 162 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97547669 |
| 163 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96719205 |
| 164 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96283245 |
| 165 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95813043 |
| 166 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95739549 |
| 167 | * EWS_26573619_Chip-Seq_HEK293_Human | 0.94838780 |
| 168 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94793521 |
| 169 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94473367 |
| 170 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94007218 |
| 171 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.93913284 |
| 172 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93479932 |
| 173 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93195877 |
| 174 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93099889 |
| 175 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92217595 |
| 176 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92151945 |
| 177 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92151945 |
| 178 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.92068829 |
| 179 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91775514 |
| 180 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91561816 |
| 181 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90970340 |
| 182 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90465857 |
| 183 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89811305 |
| 184 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89588451 |
| 185 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88899222 |
| 186 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87107171 |
| 187 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86609999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 3.82038844 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.30233866 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 2.83494267 |
| 4 | MP0004043_abnormal_pH_regulation | 2.79966931 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.57873893 |
| 6 | MP0006054_spinal_hemorrhage | 2.45043806 |
| 7 | MP0003646_muscle_fatigue | 2.33993148 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.32139680 |
| 9 | * MP0005387_immune_system_phenotype | 2.28886259 |
| 10 | * MP0001790_abnormal_immune_system | 2.28886259 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.26561434 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.23772709 |
| 13 | * MP0000685_abnormal_immune_system | 2.23048904 |
| 14 | MP0000427_abnormal_hair_cycle | 2.21448659 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.20175938 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.16994650 |
| 17 | * MP0001800_abnormal_humoral_immune | 2.16440767 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.15678652 |
| 19 | MP0001873_stomach_inflammation | 2.15253065 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.14885261 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 2.07118370 |
| 22 | MP0002876_abnormal_thyroid_physiology | 2.05424813 |
| 23 | MP0009764_decreased_sensitivity_to | 2.04955616 |
| 24 | MP0000579_abnormal_nail_morphology | 1.92316088 |
| 25 | MP0009840_abnormal_foam_cell | 1.91616202 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.89493486 |
| 27 | MP0002653_abnormal_ependyma_morphology | 1.81104713 |
| 28 | MP0002006_tumorigenesis | 1.80723676 |
| 29 | * MP0004947_skin_inflammation | 1.79672346 |
| 30 | * MP0002452_abnormal_antigen_presenting | 1.77663080 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77230231 |
| 32 | MP0005671_abnormal_response_to | 1.75533379 |
| 33 | MP0004381_abnormal_hair_follicle | 1.73936627 |
| 34 | * MP0002405_respiratory_system_inflammati | 1.73447943 |
| 35 | MP0005023_abnormal_wound_healing | 1.71825983 |
| 36 | MP0003718_maternal_effect | 1.69928434 |
| 37 | * MP0002420_abnormal_adaptive_immunity | 1.67633947 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.67519135 |
| 39 | MP0005410_abnormal_fertilization | 1.67230967 |
| 40 | * MP0002723_abnormal_immune_serum | 1.66154520 |
| 41 | MP0000858_altered_metastatic_potential | 1.65759310 |
| 42 | * MP0001819_abnormal_immune_cell | 1.64757139 |
| 43 | MP0002398_abnormal_bone_marrow | 1.64426887 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.62702555 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.60443023 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.58000750 |
| 47 | * MP0005000_abnormal_immune_tolerance | 1.56243170 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.55617893 |
| 49 | MP0000490_abnormal_crypts_of | 1.51398040 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.49804527 |
| 51 | MP0009785_altered_susceptibility_to | 1.48616795 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.48362368 |
| 53 | MP0000372_irregular_coat_pigmentation | 1.46169005 |
| 54 | MP0006072_abnormal_retinal_apoptosis | 1.45570551 |
| 55 | MP0004885_abnormal_endolymph | 1.44446802 |
| 56 | * MP0000716_abnormal_immune_system | 1.43431701 |
| 57 | MP0003866_abnormal_defecation | 1.42474542 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 1.41325444 |
| 59 | MP0003436_decreased_susceptibility_to | 1.40903483 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.40470740 |
| 61 | MP0005379_endocrine/exocrine_gland_phen | 1.39691379 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.39615370 |
| 63 | MP0002254_reproductive_system_inflammat | 1.39293355 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.38135841 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.37639635 |
| 66 | * MP0002722_abnormal_immune_system | 1.36160643 |
| 67 | MP0003303_peritoneal_inflammation | 1.34514767 |
| 68 | MP0003136_yellow_coat_color | 1.32814083 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.32162067 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.32162067 |
| 71 | MP0003011_delayed_dark_adaptation | 1.32079949 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.31488118 |
| 73 | * MP0000689_abnormal_spleen_morphology | 1.31305280 |
| 74 | MP0005025_abnormal_response_to | 1.31117186 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.30789850 |
| 76 | MP0003045_fibrosis | 1.30742656 |
| 77 | MP0005275_abnormal_skin_tensile | 1.27911840 |
| 78 | MP0000467_abnormal_esophagus_morphology | 1.26872067 |
| 79 | MP0002060_abnormal_skin_morphology | 1.26766463 |
| 80 | MP0005171_absent_coat_pigmentation | 1.22970468 |
| 81 | MP0002933_joint_inflammation | 1.20295945 |
| 82 | * MP0002429_abnormal_blood_cell | 1.17900246 |
| 83 | MP0003091_abnormal_cell_migration | 1.17745172 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.16413416 |
| 85 | MP0005389_reproductive_system_phenotype | 1.15931290 |
| 86 | * MP0001845_abnormal_inflammatory_respons | 1.15460902 |
| 87 | MP0003279_aneurysm | 1.12074630 |
| 88 | MP0001919_abnormal_reproductive_system | 1.11613237 |
| 89 | MP0009278_abnormal_bone_marrow | 1.11567998 |
| 90 | MP0002163_abnormal_gland_morphology | 1.10613062 |
| 91 | MP0003941_abnormal_skin_development | 1.09992081 |
| 92 | MP0000230_abnormal_systemic_arterial | 1.08760107 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 1.07361209 |
| 94 | MP0003693_abnormal_embryo_hatching | 1.06804288 |
| 95 | * MP0001216_abnormal_epidermal_layer | 1.05760310 |
| 96 | MP0010386_abnormal_urinary_bladder | 1.03754159 |
| 97 | MP0005253_abnormal_eye_physiology | 1.02962192 |
| 98 | MP0001853_heart_inflammation | 1.01584145 |
| 99 | MP0002019_abnormal_tumor_incidence | 1.00877338 |
| 100 | MP0002796_impaired_skin_barrier | 1.00587141 |
| 101 | MP0003183_abnormal_peptide_metabolism | 1.00472278 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 1.00205537 |
| 103 | MP0000371_diluted_coat_color | 1.00167262 |
| 104 | MP0008872_abnormal_physiological_respon | 1.00119400 |
| 105 | MP0003724_increased_susceptibility_to | 0.99531320 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.98577351 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.97843851 |
| 108 | MP0001958_emphysema | 0.97798170 |
| 109 | MP0000477_abnormal_intestine_morphology | 0.96861967 |
| 110 | MP0008438_abnormal_cutaneous_collagen | 0.94968110 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.94801319 |
| 112 | MP0008961_abnormal_basal_metabolism | 0.94263265 |
| 113 | MP0002009_preneoplasia | 0.94123800 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.93836264 |
| 115 | MP0002132_abnormal_respiratory_system | 0.92472319 |
| 116 | MP0005501_abnormal_skin_physiology | 0.90610383 |
| 117 | MP0008007_abnormal_cellular_replicative | 0.89725981 |
| 118 | MP0008877_abnormal_DNA_methylation | 0.89483020 |
| 119 | * MP0002419_abnormal_innate_immunity | 0.89435726 |
| 120 | MP0010771_integument_phenotype | 0.89400963 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.89215823 |
| 122 | MP0001542_abnormal_bone_strength | 0.88586335 |
| 123 | MP0005395_other_phenotype | 0.88422894 |
| 124 | MP0003806_abnormal_nucleotide_metabolis | 0.87985980 |
| 125 | MP0003448_altered_tumor_morphology | 0.87343415 |
| 126 | MP0004510_myositis | 0.87254195 |
| 127 | MP0003252_abnormal_bile_duct | 0.86814628 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.86208955 |
| 129 | MP0004142_abnormal_muscle_tone | 0.86025956 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.85994181 |
| 131 | MP0005360_urolithiasis | 0.85323985 |
| 132 | MP0001986_abnormal_taste_sensitivity | 0.85204197 |
| 133 | MP0008469_abnormal_protein_level | 0.84712876 |
| 134 | MP0005310_abnormal_salivary_gland | 0.83300724 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.82307088 |
| 136 | MP0003828_pulmonary_edema | 0.81908496 |
| 137 | MP0000383_abnormal_hair_follicle | 0.81604209 |
| 138 | MP0005390_skeleton_phenotype | 0.80852191 |
| 139 | MP0002098_abnormal_vibrissa_morphology | 0.79289803 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.79238802 |
| 141 | MP0000470_abnormal_stomach_morphology | 0.79135879 |
| 142 | MP0006082_CNS_inflammation | 0.79064142 |
| 143 | MP0000350_abnormal_cell_proliferation | 0.78551244 |
| 144 | MP0008004_abnormal_stomach_pH | 0.77572863 |
| 145 | MP0000613_abnormal_salivary_gland | 0.77344705 |
| 146 | MP0000377_abnormal_hair_follicle | 0.77264553 |
| 147 | MP0002998_abnormal_bone_remodeling | 0.77249218 |
| 148 | MP0000537_abnormal_urethra_morphology | 0.76857398 |
| 149 | MP0005503_abnormal_tendon_morphology | 0.76685689 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.75602084 |
| 151 | MP0002138_abnormal_hepatobiliary_system | 0.73787030 |
| 152 | MP0010307_abnormal_tumor_latency | 0.73443951 |
| 153 | MP0001879_abnormal_lymphatic_vessel | 0.72835876 |
| 154 | MP0002136_abnormal_kidney_physiology | 0.72433821 |
| 155 | MP0010678_abnormal_skin_adnexa | 0.72319276 |
| 156 | MP0001191_abnormal_skin_condition | 0.71648613 |
| 157 | MP0003795_abnormal_bone_structure | 0.71287285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nasal polyposis (HP:0100582) | 4.27805417 |
| 2 | Recurrent bronchitis (HP:0002837) | 4.22583788 |
| 3 | Pancreatic cysts (HP:0001737) | 3.93368508 |
| 4 | Abnormality of the nasal mucosa (HP:0000433) | 3.72562317 |
| 5 | Congenital stationary night blindness (HP:0007642) | 3.47211350 |
| 6 | Molar tooth sign on MRI (HP:0002419) | 3.45187732 |
| 7 | Abnormality of midbrain morphology (HP:0002418) | 3.45187732 |
| 8 | Tubular atrophy (HP:0000092) | 3.41459851 |
| 9 | Congenital sensorineural hearing impairment (HP:0008527) | 3.39105034 |
| 10 | Chronic otitis media (HP:0000389) | 3.32910914 |
| 11 | T lymphocytopenia (HP:0005403) | 3.23746160 |
| 12 | Abnormality of the fingertips (HP:0001211) | 3.19500453 |
| 13 | Aortic aneurysm (HP:0004942) | 3.15892679 |
| 14 | IgM deficiency (HP:0002850) | 3.11689726 |
| 15 | Genetic anticipation (HP:0003743) | 3.10677615 |
| 16 | Abnormality of T cell number (HP:0011839) | 3.10427526 |
| 17 | Pustule (HP:0200039) | 3.01681883 |
| 18 | Milia (HP:0001056) | 3.00126875 |
| 19 | Bronchitis (HP:0012387) | 2.94395249 |
| 20 | Abnormality of the renal cortex (HP:0011035) | 2.93523111 |
| 21 | Chronic sinusitis (HP:0011109) | 2.87245707 |
| 22 | Nephronophthisis (HP:0000090) | 2.84449905 |
| 23 | Pancreatic fibrosis (HP:0100732) | 2.82670375 |
| 24 | Atrophic scars (HP:0001075) | 2.80906745 |
| 25 | Recurrent viral infections (HP:0004429) | 2.80112121 |
| 26 | Type II lissencephaly (HP:0007260) | 2.79067127 |
| 27 | Agammaglobulinemia (HP:0004432) | 2.78907531 |
| 28 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.75537978 |
| 29 | Increased IgE level (HP:0003212) | 2.74466247 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 2.72397593 |
| 31 | Erythroderma (HP:0001019) | 2.70335302 |
| 32 | Rectal prolapse (HP:0002035) | 2.69964107 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.66370306 |
| 34 | Stomatitis (HP:0010280) | 2.65590293 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.65249297 |
| 36 | IgA deficiency (HP:0002720) | 2.64226953 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.64162376 |
| 38 | Abnormality of T cells (HP:0002843) | 2.63599748 |
| 39 | Palmoplantar hyperkeratosis (HP:0000972) | 2.63187834 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.62466743 |
| 41 | Onycholysis (HP:0001806) | 2.61856637 |
| 42 | Chronic hepatic failure (HP:0100626) | 2.61520424 |
| 43 | Fragile nails (HP:0001808) | 2.61182950 |
| 44 | Parakeratosis (HP:0001036) | 2.60833342 |
| 45 | Thrombocytosis (HP:0001894) | 2.60651132 |
| 46 | True hermaphroditism (HP:0010459) | 2.60354326 |
| 47 | Conical tooth (HP:0000698) | 2.60281719 |
| 48 | Thick nail (HP:0001805) | 2.58426080 |
| 49 | Stomach cancer (HP:0012126) | 2.57839052 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 2.55849315 |
| 51 | 11 pairs of ribs (HP:0000878) | 2.55176580 |
| 52 | Keratoconus (HP:0000563) | 2.54834403 |
| 53 | Increased corneal curvature (HP:0100692) | 2.54834403 |
| 54 | Furrowed tongue (HP:0000221) | 2.54832582 |
| 55 | Pendular nystagmus (HP:0012043) | 2.52220811 |
| 56 | Emphysema (HP:0002097) | 2.50753724 |
| 57 | Hypoplasia of the fovea (HP:0007750) | 2.49233948 |
| 58 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.49233948 |
| 59 | Optic neuritis (HP:0100653) | 2.48901218 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.48901218 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.48046059 |
| 62 | Attenuation of retinal blood vessels (HP:0007843) | 2.46325697 |
| 63 | Abolished electroretinogram (ERG) (HP:0000550) | 2.46313520 |
| 64 | Abnormality of nail color (HP:0100643) | 2.45891918 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.45612659 |
| 66 | Cellulitis (HP:0100658) | 2.43364954 |
| 67 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.42182507 |
| 68 | Lymphopenia (HP:0001888) | 2.41971963 |
| 69 | Colitis (HP:0002583) | 2.40494922 |
| 70 | Palmar hyperkeratosis (HP:0010765) | 2.40058818 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.37115833 |
| 72 | * Recurrent fungal infections (HP:0002841) | 2.36367666 |
| 73 | Amelogenesis imperfecta (HP:0000705) | 2.34689716 |
| 74 | Lip pit (HP:0100267) | 2.33719671 |
| 75 | Hypoplasia of the uterus (HP:0000013) | 2.31950566 |
| 76 | Verrucae (HP:0200043) | 2.31418652 |
| 77 | Papilloma (HP:0012740) | 2.31418652 |
| 78 | Alopecia of scalp (HP:0002293) | 2.30884098 |
| 79 | Concave nail (HP:0001598) | 2.30283448 |
| 80 | Abnormality of the axillary hair (HP:0100134) | 2.29736674 |
| 81 | Abnormality of secondary sexual hair (HP:0009888) | 2.29736674 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.28938691 |
| 83 | Polydipsia (HP:0001959) | 2.28938691 |
| 84 | Hyperventilation (HP:0002883) | 2.26438971 |
| 85 | Cystic liver disease (HP:0006706) | 2.26065153 |
| 86 | Cerebral aneurysm (HP:0004944) | 2.25715237 |
| 87 | Large for gestational age (HP:0001520) | 2.25565370 |
| 88 | Abnormality of the renal collecting system (HP:0004742) | 2.25119624 |
| 89 | Congenital, generalized hypertrichosis (HP:0004540) | 2.24650883 |
| 90 | Abnormal hemoglobin (HP:0011902) | 2.23675422 |
| 91 | Mesangial abnormality (HP:0001966) | 2.22765310 |
| 92 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.22214495 |
| 93 | Aortic dissection (HP:0002647) | 2.22139964 |
| 94 | Ectropion (HP:0000656) | 2.22119599 |
| 95 | Myositis (HP:0100614) | 2.21324379 |
| 96 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.15757162 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.15672190 |
| 98 | Ureteral stenosis (HP:0000071) | 2.15131579 |
| 99 | Panhypogammaglobulinemia (HP:0003139) | 2.14227969 |
| 100 | Bronchiectasis (HP:0002110) | 2.14030452 |
| 101 | Missing ribs (HP:0000921) | 2.12046155 |
| 102 | Gastrointestinal stroma tumor (HP:0100723) | 2.10916130 |
| 103 | Abnormality of the pons (HP:0007361) | 2.10400486 |
| 104 | Recurrent sinusitis (HP:0011108) | 2.10007759 |
| 105 | Ureteral obstruction (HP:0006000) | 2.07861981 |
| 106 | Duplicated collecting system (HP:0000081) | 2.07820622 |
| 107 | Increased density of long bones (HP:0006392) | 2.06933413 |
| 108 | Reticulocytopenia (HP:0001896) | 2.06416304 |
| 109 | Eczematoid dermatitis (HP:0000976) | 2.05160271 |
| 110 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.05056844 |
| 111 | Sparse lateral eyebrow (HP:0005338) | 2.04974178 |
| 112 | Abnormality of B cell number (HP:0010975) | 2.03984816 |
| 113 | B lymphocytopenia (HP:0010976) | 2.03984816 |
| 114 | Broad face (HP:0000283) | 2.03359549 |
| 115 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02474043 |
| 116 | Abnormality of alanine metabolism (HP:0010916) | 2.02474043 |
| 117 | Hyperalaninemia (HP:0003348) | 2.02474043 |
| 118 | Progressive inability to walk (HP:0002505) | 2.02124937 |
| 119 | Clumsiness (HP:0002312) | 2.01935614 |
| 120 | Dilatation of the ascending aorta (HP:0005111) | 1.99800429 |
| 121 | Albinism (HP:0001022) | 1.99227873 |
| 122 | Hypoplasia of the pons (HP:0012110) | 1.98800380 |
| 123 | Inability to walk (HP:0002540) | 1.97576395 |
| 124 | Medial flaring of the eyebrow (HP:0010747) | 1.96233590 |
| 125 | Cervical subluxation (HP:0003308) | 1.95421894 |
| 126 | Severe muscular hypotonia (HP:0006829) | 1.95381483 |
| 127 | Chronic diarrhea (HP:0002028) | 1.95354913 |
| 128 | Autoimmune thrombocytopenia (HP:0001973) | 1.95338368 |
| 129 | Prostate neoplasm (HP:0100787) | 1.94319320 |
| 130 | Widely spaced teeth (HP:0000687) | 1.94169087 |
| 131 | Persistence of primary teeth (HP:0006335) | 1.93628984 |
| 132 | Abnormality of the fovea (HP:0000493) | 1.92898601 |
| 133 | Hypoplasia of the thymus (HP:0000778) | 1.91296957 |
| 134 | Hypoplastic labia majora (HP:0000059) | 1.90498655 |
| 135 | Periodontitis (HP:0000704) | 1.89817015 |
| 136 | Basal cell carcinoma (HP:0002671) | 1.88636199 |
| 137 | * Skin ulcer (HP:0200042) | 1.88430561 |
| 138 | Abnormality of the gastric mucosa (HP:0004295) | 1.88262937 |
| 139 | Meningitis (HP:0001287) | 1.87904278 |
| 140 | Mitral regurgitation (HP:0001653) | 1.87518136 |
| 141 | Abnormal biliary tract physiology (HP:0012439) | 1.87497289 |
| 142 | Bile duct proliferation (HP:0001408) | 1.87497289 |
| 143 | Vacuolated lymphocytes (HP:0001922) | 1.87125556 |
| 144 | Fair hair (HP:0002286) | 1.87046495 |
| 145 | Macular degeneration (HP:0000608) | 1.86662497 |
| 146 | Abnormality of oral frenula (HP:0000190) | 1.85911558 |
| 147 | Methylmalonic acidemia (HP:0002912) | 1.84978660 |
| 148 | IgG deficiency (HP:0004315) | 1.84598239 |
| 149 | Chorioretinal atrophy (HP:0000533) | 1.84530937 |
| 150 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.84265013 |
| 151 | Eosinophilia (HP:0001880) | 1.83505603 |
| 152 | Optic nerve coloboma (HP:0000588) | 1.82941340 |
| 153 | Autoimmune hemolytic anemia (HP:0001890) | 1.80365569 |
| 154 | Interstitial pulmonary disease (HP:0006530) | 1.79517211 |
| 155 | Poikiloderma (HP:0001029) | 1.79468753 |
| 156 | Trismus (HP:0000211) | 1.79414049 |
| 157 | Plantar hyperkeratosis (HP:0007556) | 1.78845467 |
| 158 | Cerebellar dysplasia (HP:0007033) | 1.78444285 |
| 159 | Thoracolumbar scoliosis (HP:0002944) | 1.77783486 |
| 160 | Corneal erosion (HP:0200020) | 1.75925344 |
| 161 | Adactyly (HP:0009776) | 1.75286546 |
| 162 | Recurrent cutaneous fungal infections (HP:0011370) | 1.74888214 |
| 163 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.74888214 |
| 164 | Colon cancer (HP:0003003) | 1.74858962 |
| 165 | Generalized hypopigmentation of hair (HP:0011358) | 1.74420437 |
| 166 | Increased IgM level (HP:0003496) | 1.73891533 |
| 167 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73639392 |
| 168 | Lymphoma (HP:0002665) | 1.72593188 |
| 169 | Azoospermia (HP:0000027) | 1.71798580 |
| 170 | Recurrent otitis media (HP:0000403) | 1.71711404 |
| 171 | Polyuria (HP:0000103) | 1.71275869 |
| 172 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71076253 |
| 173 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71076253 |
| 174 | Fragile skin (HP:0001030) | 1.66087539 |
| 175 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.63571573 |
| 176 | Long palpebral fissure (HP:0000637) | 1.61991596 |
| 177 | Vasculitis (HP:0002633) | 1.61693263 |
| 178 | Multiple enchondromatosis (HP:0005701) | 1.61380387 |
| 179 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.61284403 |
| 180 | Orchitis (HP:0100796) | 1.60653348 |
| 181 | Right ventricular cardiomyopathy (HP:0011663) | 1.60501914 |
| 182 | * Cheilitis (HP:0100825) | 1.60086425 |
| 183 | Combined immunodeficiency (HP:0005387) | 1.59233477 |
| 184 | Hematochezia (HP:0002573) | 1.58515820 |
| 185 | Ankle contracture (HP:0006466) | 1.56295000 |
| 186 | Biliary tract neoplasm (HP:0100574) | 1.55999207 |
| 187 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.55951999 |
| 188 | Osteolytic defects of the hand bones (HP:0009699) | 1.55951999 |
| 189 | Ulnar bowing (HP:0003031) | 1.55830600 |
| 190 | Selective tooth agenesis (HP:0001592) | 1.55596821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 3.99681616 |
| 2 | ACVR1B | 3.83572446 |
| 3 | MAP4K1 | 3.57980604 |
| 4 | ERN1 | 3.20183412 |
| 5 | BMPR1B | 3.03302987 |
| 6 | GRK1 | 2.82574450 |
| 7 | TLK1 | 2.56571333 |
| 8 | MST4 | 2.52778374 |
| 9 | STK10 | 2.49631845 |
| 10 | ZAK | 2.48827447 |
| 11 | EEF2K | 2.46615471 |
| 12 | JAK3 | 2.45494045 |
| 13 | MAP3K10 | 2.25785649 |
| 14 | NLK | 2.02308039 |
| 15 | RPS6KA4 | 1.96503722 |
| 16 | LRRK2 | 1.93704067 |
| 17 | MAP4K2 | 1.85819759 |
| 18 | GRK7 | 1.84032452 |
| 19 | FGFR4 | 1.80692434 |
| 20 | TYK2 | 1.73367753 |
| 21 | ZAP70 | 1.73245462 |
| 22 | MAPK15 | 1.73026703 |
| 23 | FGFR3 | 1.72211266 |
| 24 | ITK | 1.72085914 |
| 25 | SIK1 | 1.68983890 |
| 26 | FLT3 | 1.68399851 |
| 27 | TXK | 1.67612367 |
| 28 | IKBKE | 1.66160973 |
| 29 | GRK6 | 1.64799528 |
| 30 | WNK4 | 1.60668810 |
| 31 | MAP3K14 | 1.59897264 |
| 32 | EPHA2 | 1.59530857 |
| 33 | RPS6KB2 | 1.57901290 |
| 34 | TBK1 | 1.52562276 |
| 35 | NME2 | 1.49550838 |
| 36 | PKN2 | 1.45735347 |
| 37 | EPHA3 | 1.45303271 |
| 38 | BTK | 1.43831202 |
| 39 | CDK12 | 1.42473017 |
| 40 | JAK1 | 1.37722545 |
| 41 | FRK | 1.36997600 |
| 42 | INSRR | 1.36570190 |
| 43 | MAP3K3 | 1.36346624 |
| 44 | DDR2 | 1.33476715 |
| 45 | TRIB3 | 1.31501612 |
| 46 | MAPKAPK3 | 1.28835937 |
| 47 | PIM2 | 1.27440222 |
| 48 | PINK1 | 1.26249821 |
| 49 | TESK1 | 1.25842045 |
| 50 | ADRBK1 | 1.20019858 |
| 51 | PIK3CA | 1.18724497 |
| 52 | TEC | 1.16399428 |
| 53 | MATK | 1.16045728 |
| 54 | IRAK1 | 1.15215259 |
| 55 | IKBKB | 1.13825641 |
| 56 | RIPK1 | 1.12649966 |
| 57 | EPHB1 | 1.08881486 |
| 58 | CSK | 1.08879353 |
| 59 | TAOK3 | 1.08240846 |
| 60 | PTK6 | 1.07852913 |
| 61 | CHUK | 1.07332118 |
| 62 | MAP2K6 | 1.06487465 |
| 63 | TTN | 1.05468343 |
| 64 | TGFBR2 | 1.04285649 |
| 65 | TGFBR1 | 1.03576965 |
| 66 | CDC42BPA | 0.98305786 |
| 67 | MARK3 | 0.97140097 |
| 68 | OXSR1 | 0.96231712 |
| 69 | MUSK | 0.94804404 |
| 70 | HIPK2 | 0.94713442 |
| 71 | IRAK3 | 0.94373119 |
| 72 | DMPK | 0.92788491 |
| 73 | PIM1 | 0.92368941 |
| 74 | MET | 0.92293809 |
| 75 | LCK | 0.87508011 |
| 76 | HCK | 0.86369763 |
| 77 | PASK | 0.83333383 |
| 78 | MAPK13 | 0.82908464 |
| 79 | STK39 | 0.81933865 |
| 80 | SIK3 | 0.81688979 |
| 81 | KIT | 0.81216484 |
| 82 | FER | 0.80878556 |
| 83 | CSF1R | 0.77025253 |
| 84 | MAP2K2 | 0.76876613 |
| 85 | ABL2 | 0.76289021 |
| 86 | PKN1 | 0.75872225 |
| 87 | PRKAA2 | 0.75715662 |
| 88 | DAPK2 | 0.75643064 |
| 89 | PRKD2 | 0.74509038 |
| 90 | PTK2B | 0.74189337 |
| 91 | WNK3 | 0.74078471 |
| 92 | NEK9 | 0.73050380 |
| 93 | SYK | 0.71611636 |
| 94 | NEK2 | 0.70634610 |
| 95 | SCYL2 | 0.70205659 |
| 96 | PRKCE | 0.69757517 |
| 97 | LMTK2 | 0.68060830 |
| 98 | CDK6 | 0.67323597 |
| 99 | IRAK4 | 0.67138345 |
| 100 | TAOK1 | 0.66615868 |
| 101 | PTK2 | 0.66436763 |
| 102 | NUAK1 | 0.65339827 |
| 103 | DYRK1B | 0.65235146 |
| 104 | MAPK7 | 0.61050122 |
| 105 | EPHB2 | 0.60876730 |
| 106 | MAP3K8 | 0.60483636 |
| 107 | STK38 | 0.60457315 |
| 108 | SIK2 | 0.60150094 |
| 109 | TRPM7 | 0.60062092 |
| 110 | MAPKAPK2 | 0.59366488 |
| 111 | STK24 | 0.59211045 |
| 112 | PDGFRA | 0.58776300 |
| 113 | AKT3 | 0.58028708 |
| 114 | CDK4 | 0.58011267 |
| 115 | MAP3K7 | 0.56483004 |
| 116 | TNK2 | 0.56312850 |
| 117 | MAP3K9 | 0.55735507 |
| 118 | MAP2K3 | 0.55716011 |
| 119 | STK3 | 0.55347753 |
| 120 | PAK2 | 0.52470291 |
| 121 | PRKG2 | 0.52380188 |
| 122 | PIK3CG | 0.52325016 |
| 123 | MAP2K1 | 0.52134180 |
| 124 | LATS1 | 0.50421976 |
| 125 | MOS | 0.49760564 |
| 126 | TESK2 | 0.49510249 |
| 127 | MAPKAPK5 | 0.49066892 |
| 128 | MTOR | 0.47954510 |
| 129 | PRKCI | 0.47873364 |
| 130 | RPS6KC1 | 0.45780866 |
| 131 | RPS6KL1 | 0.45780866 |
| 132 | MAPK11 | 0.45287042 |
| 133 | ABL1 | 0.44877483 |
| 134 | PRKCH | 0.44609106 |
| 135 | MAP3K13 | 0.43903802 |
| 136 | DYRK3 | 0.43256427 |
| 137 | RPS6KA6 | 0.42845454 |
| 138 | CDK7 | 0.42169874 |
| 139 | JAK2 | 0.41790047 |
| 140 | CDK9 | 0.41243669 |
| 141 | MYLK | 0.37223612 |
| 142 | CSNK1A1 | 0.36690669 |
| 143 | CAMKK2 | 0.36548203 |
| 144 | MST1R | 0.34070817 |
| 145 | IGF1R | 0.31840089 |
| 146 | LYN | 0.30349165 |
| 147 | PRKCZ | 0.30125020 |
| 148 | PRKCQ | 0.29753943 |
| 149 | TIE1 | 0.29224367 |
| 150 | CAMK1D | 0.27000472 |
| 151 | PRKAA1 | 0.26993606 |
| 152 | GSK3A | 0.26598282 |
| 153 | EIF2AK3 | 0.25952064 |
| 154 | PRKACA | 0.25868040 |
| 155 | EIF2AK2 | 0.25237082 |
| 156 | BCKDK | 0.25058153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.57302173 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.23174254 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.77386364 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.59240353 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.44348501 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.36876648 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.35104305 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.30980395 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.24289496 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.19663955 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19397382 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.09710707 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.07853673 |
| 14 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.04221565 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02686070 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.93835827 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.93711238 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.88311766 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86054327 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.77627944 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.69243427 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68332449 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.67943205 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64996076 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.62551336 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62359539 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57209057 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56768722 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.52066474 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.51923537 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47834230 |
| 32 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.46297601 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44390173 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43596337 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42730420 |
| 36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.39111689 |
| 37 | Adherens junction_Homo sapiens_hsa04520 | 1.38709286 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.37039116 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.36118064 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34050381 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32790203 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32727393 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 1.31857884 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31832385 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.31557558 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30873675 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 1.30650362 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.30373695 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.28711607 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28606811 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28527085 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.27110139 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 1.26355047 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.25282771 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.22968409 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22697810 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21581004 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.21422508 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20909133 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20105246 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.19064643 |
| 62 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.14680602 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.13487248 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.11999275 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 1.10232573 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07771053 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07592397 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 1.05162418 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04591874 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01461579 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00938238 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 1.00756604 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00615361 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00172870 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00028634 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97821340 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96370569 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95895231 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94469014 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92573569 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.91986191 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.91692053 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90114315 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89627096 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89462990 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87892175 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.87801366 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.86912500 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84549771 |
| 90 | Base excision repair_Homo sapiens_hsa03410 | 0.83831158 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83567938 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83480143 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83245190 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82179509 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82089904 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.81624012 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80686030 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78925676 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76218703 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.74120328 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72609176 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.72505295 |
| 103 | Mismatch repair_Homo sapiens_hsa03430 | 0.72150562 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70439044 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69325078 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68938488 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.68877775 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68710955 |
| 109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68255327 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67645965 |
| 111 | Tuberculosis_Homo sapiens_hsa05152 | 0.66788239 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64754278 |
| 113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64531071 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64293348 |
| 115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64269758 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63600641 |
| 117 | DNA replication_Homo sapiens_hsa03030 | 0.62037887 |
| 118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61957655 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60684609 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60532204 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60243488 |
| 122 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59640980 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.59444171 |
| 124 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58948646 |
| 125 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58940554 |
| 126 | Spliceosome_Homo sapiens_hsa03040 | 0.58600617 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58181680 |
| 128 | Taste transduction_Homo sapiens_hsa04742 | 0.58095853 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57321682 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57039049 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56743982 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56643922 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56640703 |
| 134 | Peroxisome_Homo sapiens_hsa04146 | 0.56524600 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56397556 |
| 136 | Protein export_Homo sapiens_hsa03060 | 0.56290896 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.56174463 |
| 138 | Homologous recombination_Homo sapiens_hsa03440 | 0.55695574 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.55540253 |
| 140 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55328238 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54563261 |
| 142 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54388682 |
| 143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50162767 |
| 144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50122305 |
| 145 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49552346 |
| 146 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49007047 |
| 147 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48679397 |
| 148 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48013395 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47732019 |
| 150 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46840499 |
| 151 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46635227 |
| 152 | Lysine degradation_Homo sapiens_hsa00310 | 0.45852669 |
| 153 | RNA polymerase_Homo sapiens_hsa03020 | 0.38660773 |
| 154 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37142752 |
| 155 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36797623 |
| 156 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36243959 |
| 157 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31696264 |
| 158 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31433636 |
| 159 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29216873 |
| 160 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.28439979 |
| 161 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28272072 |
| 162 | RNA degradation_Homo sapiens_hsa03018 | 0.27691221 |

